Manufacturers Life Insurance Company, The Ironwood Pharmaceuticals Inc Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 54,522 shares of IRWD stock, worth $245,894. This represents 0.0% of its overall portfolio holdings.
Number of Shares
54,522
Previous 77,074
29.26%
Holding current value
$245,894
Previous $502,000
55.38%
% of portfolio
0.0%
Previous 0.0%
Shares
33 transactions
Others Institutions Holding IRWD
# of Institutions
235Shares Held
162MCall Options Held
11.2MPut Options Held
9.1K-
Black Rock Inc. New York, NY22.9MShares$103 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA22MShares$99.4 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$73.9 Million16.75% of portfolio
-
Pacer Advisors, Inc. Malvern, PA11.3MShares$50.9 Million0.11% of portfolio
-
State Street Corp Boston, MA9.92MShares$44.7 Million0.0% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $691M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...